Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
- PMID: 33992040
- PMCID: PMC8569800
- DOI: 10.3906/sag-2012-107
Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
Abstract
Background/aim: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality.
Materials and methods: HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haematology ICU (H-ICU) were included in this study. Patients’ demographic characteristics and ICU data were recorded retrospectively. Differences in the ICU course and prognosis between these two groups were determined.
Results: A total of 251 patients (102 from GM-ICU, 149 from H-ICU) were included in this study. The disease severity and organ failure scores at ICU admission and underlying HMs were not different between the two groups. Patients waited longer for admission to GM- ICU. Therapeutic procedures were performed significantly more frequently in GM-ICU. ICU complications were not different between the groups. ICU mortality rates were higher in GM-ICU (59.8% vs 37.6%, p = 0.006).
Conclusion: A separate ICU allocated for haematology patients will allow timely and rapid admission of HM patients to ICU. Thus, mortality rates of HM patients needing ICU care will decline.
Keywords: patients with haematological malignancies; Intensive care unit; separate intensive care unit; intensive care unit mortality.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Conflict of interest statement
The authors declare that they have no conflicts of interest. No financial support or grant was received for this study.
Similar articles
-
Risk factors for ICU mortality in patients with hematological malignancies: a singlecenter, retrospective cohort study from Turkey.Turk J Med Sci. 2023 Feb;53(1):340-351. doi: 10.55730/1300-0144.5590. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945922 Free PMC article.
-
Lactate level is an independent predictor of mortality in patients with hematologic malignancy receiving urgent chemotherapy in intensive care unit.Curr Res Transl Med. 2024 Dec;72(4):103451. doi: 10.1016/j.retram.2024.103451. Epub 2024 Apr 22. Curr Res Transl Med. 2024. PMID: 38677199
-
Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.Br J Anaesth. 2012 Mar;108(3):452-9. doi: 10.1093/bja/aer449. Epub 2012 Jan 31. Br J Anaesth. 2012. PMID: 22298243 Review.
-
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.Nephrol Dial Transplant. 2005 Mar;20(3):552-8. doi: 10.1093/ndt/gfh637. Epub 2005 Jan 25. Nephrol Dial Transplant. 2005. PMID: 15671075
-
Critically ill cancer patient in intensive care unit: issues that arise.J Crit Care. 2014 Oct;29(5):817-22. doi: 10.1016/j.jcrc.2014.04.007. Epub 2014 Apr 24. J Crit Care. 2014. PMID: 24857640 Review.
Cited by
-
Risk factors for ICU mortality in patients with hematological malignancies: a singlecenter, retrospective cohort study from Turkey.Turk J Med Sci. 2023 Feb;53(1):340-351. doi: 10.55730/1300-0144.5590. Epub 2023 Feb 22. Turk J Med Sci. 2023. PMID: 36945922 Free PMC article.
-
[The value of sequential organ failure assessment and its dynamic changes in predicting mortality in hematology intensive care unit].Zhonghua Xue Ye Xue Za Zhi. 2025 Jan 14;46(1):31-38. doi: 10.3760/cma.j.cn121090-20241130-00510. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40059679 Free PMC article. Chinese.
References
-
- Thiéry G Azoulay E Darmon M Ciroldi M De Miranda Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. Journal of Clinical Oncology. 2005;23:4406–4413. - PubMed
-
- Aygencel G Turkoglu M Turkoz Sucak G Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. Journal of Critical Care. 2014;29:618–626. - PubMed
-
- Soares M Caruso P Silva E Teles JM Lobo SM Brazilian Research in Intensive Care Network (BRICNet). Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Critical Care Medicine. 2010;38:9–15. - PubMed
-
- Cherif H Martling CR Hansen J Kalin M Björkholm M. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Supportive Care in Cancer. 2007;15:1393–1398. - PubMed
-
- Namendys-Silva SA González-Herrera MO García-Guillén FJ Texcocano-Becerra J Herrera-Gómez A Outcome of critically ill patients with hematological malignancies. Annals of Hematology. 2013;92:699–705. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources